Astrana Health, Inc. (NASDAQ:ASTH) Shares Purchased by Renaissance Technologies LLC

Renaissance Technologies LLC grew its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 217.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 217,900 shares of the company's stock after buying an additional 149,300 shares during the period. Renaissance Technologies LLC owned 0.39% of Astrana Health worth $6,870,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Stifel Financial Corp purchased a new position in shares of Astrana Health during the third quarter valued at approximately $800,000. Barclays PLC bought a new stake in shares of Astrana Health during the third quarter worth $4,457,000. Geode Capital Management LLC bought a new position in shares of Astrana Health in the third quarter worth about $58,995,000. Franklin Resources Inc. bought a new stake in Astrana Health during the 3rd quarter valued at about $1,187,000. Finally, Principal Financial Group Inc. purchased a new stake in Astrana Health in the 3rd quarter valued at about $13,383,000. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Stock Performance

ASTH traded up $0.08 during midday trading on Thursday, hitting $30.98. 32,276 shares of the company were exchanged, compared to its average volume of 275,306. The company's 50 day simple moving average is $31.49 and its 200 day simple moving average is $38.71. The firm has a market capitalization of $1.55 billion, a price-to-earnings ratio of 23.82, a price-to-earnings-growth ratio of 1.37 and a beta of 1.04. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a 1-year low of $23.12 and a 1-year high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.37). The firm had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. As a group, sell-side analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ASTH. Truist Financial decreased their price target on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th. Stifel Nicolaus lowered their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Barclays initiated coverage on shares of Astrana Health in a report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price target for the company. Bank of America cut their price objective on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday, March 4th. Finally, Robert W. Baird lowered their target price on Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Astrana Health currently has an average rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.